RBC Europe’s abrdn Life Sciences Investors HQL Stock Holding History

RBC Europe’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,680	Closed	-$57.5K	–	1250
2021 Q2	$57.5K	Hold	2,680	–	–	﹤0.01%	560
2021 Q1	$52.8K	Hold	2,680	–	–	﹤0.01%	542
2020 Q4	$52.9K	Hold	2,680	–	–	﹤0.01%	502
2020 Q3	$47.1K	Hold	2,680	–	–	﹤0.01%	469
2020 Q2	$48.1K	Hold	2,680	–	–	﹤0.01%	452
2020 Q1	$40.1K	Hold	2,680	–	–	﹤0.01%	425
2019 Q4	$46.7K	Hold	2,680	–	–	﹤0.01%	466
2019 Q3	$40.5K	Hold	2,680	–	–	﹤0.01%	480
2019 Q2	$45.2K	Hold	2,680	–	–	﹤0.01%	482
2019 Q1	$45.9K	Hold	2,680	–	–	0.01%	482
2018 Q4	$40.5K	Buy	2,680 +430	+19%	+$7.57K	0.01%	479
2018 Q3	$45.9K	Hold	2,250	–	–	0.01%	496
2018 Q2	$42.3K	Buy	2,250 +1,340	+147%	+$25.2K	0.01%	502
2018 Q1	$17.5K	Hold	910	–	–	﹤0.01%	703
2017 Q4	$17.9K	Buy	910 +350	+63%	+$7.01K	﹤0.01%	706
2017 Q3	$12K	Buy	+560	New	+$11.9K	﹤0.01%	791

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

RBC Europe's HQL Position: Q3 2021 in Review

RBC Europe sold out of abrdn Life Sciences Investors (HQL) in Q3 2021, closing a stake of 2,680 shares — an estimated $57.5K sold.

RBC Europe first reported a position in HQL in Q3 2017 and held it in 16 quarters. The position peaked at $57.5K in Q2 2021. 67 funds tracked by Wall St. Rank hold HQL as of Q3 2021.

RBC Europe reported no remaining abrdn Life Sciences Investors position as of Q3 2021 after selling out during the quarter.
RBC Europe sold 2,680 abrdn Life Sciences Investors shares in Q3 2021, an estimated $57.5K.
RBC Europe first reported a position in abrdn Life Sciences Investors in Q3 2017 and held it in 16 quarters.
RBC Europe's abrdn Life Sciences Investors position peaked at $57.5K in Q2 2021.
67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2021.

Based on RBC Europe's 13F filing for Q3 2021, filed 9 Nov 2023.